Article Details

Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update

Retrieved on: 2024-11-07 21:35:45

Tags for this article:

Click the tags to see associated articles and topics

Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update. View article details on hiswai:

Excerpt

Neuroscience Pipeline Highlights · Fasedienol for the Acute Treatment of Social Anxiety Disorder (SAD) · Itruvone for Major Depressive Disorder (MDD).

Article found on: quantisnow.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo